Literature DB >> 25789709

A new T-cell activation mode for suboptimal doses of antigen under the full activation of T cells with different specificity.

Mihoko Shibuya1, Keishi Fujio1, Hirofumi Shoda1, Tomohisa Okamura1, Akiko Okamoto1, Shuji Sumitomo1, Kazuhiko Yamamoto1.   

Abstract

Loss of tolerance for autoantigens is a common feature in autoimmune diseases. Bystander T-cell activation is the activation of T cells to produce functional changes through TCR-independent stimulation. Although bystander activation may be related to tolerance loss to multiple autoantigens, the activation mechanism of T cells directed to an autoantigen with limited amount is not clear. We investigated an activation mode of T cells (designated as "associator T cells") directed to a suboptimal dose of cognate antigen X in the presence of fully activated T cells (designated as "responder T cells") directed to an optimal dose of antigen Y. In in vitro coculture, the activation of associator T cells was dependent on the presentation of antigen X, and soluble factors from activated responder T cells were not sufficient. Therefore, we conclude this activation mode is different from bystander activation and named it "extended antigen priming (EAP)". T cells with EAP showed a different phenotype compared to conventionally primed cells, suggesting the unique nature of EAP. Intriguingly, EAP was dependent on the CD40-CD40L signaling pathway. Thus, the EAP model is a T-cell activation mode for suboptimal dose of antigen and presumably related to the immune response to autoantigens in autoimmune status.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Antigen specificity; Autoimmunity; Autoreactive T cells; Bystander activation; Epitope spreading

Mesh:

Substances:

Year:  2015        PMID: 25789709     DOI: 10.1002/eji.201444965

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  1 in total

1.  Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.

Authors:  Saphala Dhital; John V Stokes; Nogi Park; Keun Seok Seo; Barbara L F Kaplan
Journal:  Cell Immunol       Date:  2016-11-09       Impact factor: 4.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.